Verition Fund Management’s Zymeworks ZYME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-114,156
Closed -$1.36M 3914
2025
Q1
$1.36M Buy
114,156
+98,342
+622% +$1.34M 0.01% 1870
2024
Q4
$232K Buy
+15,814
New +$221K ﹤0.01% 2913
2023
Q2
Sell
-61,386
Closed -$555K 2600
2023
Q1
$555K Buy
+61,386
New +$535K 0.01% 1179

Other funds holding ZYME

Verition Fund Management's ZYME Position: Q2 2025 in Review

Verition Fund Management sold out of Zymeworks (ZYME) in Q2 2025, closing a stake of 114,156 shares — an estimated $1.36M sold.

Verition Fund Management first reported a position in ZYME in Q1 2023 and held it in 3 quarters. The position peaked at $1.36M in Q1 2025. 181 funds tracked by Wall St. Rank hold ZYME as of Q2 2025.

  • Verition Fund Management reported no remaining Zymeworks position as of Q2 2025 after selling out during the quarter.
  • Verition Fund Management sold 114,156 Zymeworks shares in Q2 2025, an estimated $1.36M.
  • Verition Fund Management first reported a position in Zymeworks in Q1 2023 and held it in 3 quarters.
  • Verition Fund Management's Zymeworks position peaked at $1.36M in Q1 2025.
  • 181 funds tracked by Wall St. Rank held Zymeworks as of Q2 2025.

Based on Verition Fund Management's 13F filing for Q2 2025, filed 14 Aug 2025.